The use of melittin in therapy is not without risks. Its non-selective mechanism can damage healthy cells alongside targeted ones, leading to potential off-target effects and toxicity. Additionally, systemic administration of melittin could trigger immune responses or allergic reactions, complicating its therapeutic use. Researchers are working to modify melittin or develop delivery systems that minimize these risks.
